OutSee closes £2.5m seed funding round and establishes partnership with o2h discovery for lead drug target candidate
Cambridge, UK, 22 January 2026: We are pleased to share that Outsee, A Cambridge-based genomics and drug discovery fledgling company, has closed its £2.5 million seed round and signed what could prove an important strategic deal with o2h discovery, headquartered in Cambridge, UK, and Ahmedabad, India.